Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ciputra Development Tbk (CTRA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Ciputra Development TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Ciputra Development Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Ciputra Development Tbk trades at Rp570 (market cap 10.38T, 3.81M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp147 (market cap 576.7B, 2.39M 24h volume). The key difference: Ciputra Development Tbk is far larger — about 18× UBC Medical Indonesia Tbk.'s market cap, and Ciputra Development Tbk is more actively traded (3.81M versus 2.39M). Which is the better fit depends on your goals.

CTRALABS
Market Cap
10.38T576.7B
Volume
3.81M2.39M
Lot
38.12K23.91K
Turnover
2.19B362.17M
Average Price
574.05151.47
Value
2.19B362.17M
Indicative Equilibrium Price
565147
Indicative Equilibrium Volume
819311

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CTRA
View details
LABS
View details

About Ciputra Development Tbk

PT Ciputra Development Tbk (the Company) was established in the Republic of Indonesia originally under the name PT Citra Habitat Indonesia based on notarial deed No. 22 dated October 22, 1981. Ciputra Developments main interest is in residential and township developments which account for approximately 90% of the companies total sales. The company has nine flagship development projects.

Read more on CTRA

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS